Tenet Healthcare Posts Lower Sales, Profits On Unfavorable Impact Of Cyber Attack
Tenet Healthcare Corp’s (NYSE:THC) Q2 FY22 adjusted EPS came in at $1.50, down from $1.59 a year ago and beating…
Donald Trump Planned To Redo Jan. 7 Speech And Double-Down Against Joe Biden’s Presidential Victory: Report
Former President Donald Trump reportedly wanted to redo a speech two days after reluctantly agreeing to hand over power to current President Joe Biden’s administration.
If You Invested $1,000 In Boston Beer Stock When Truly Hard Seltzer Was Launched, Here’s How Much You’d Have Now
Well-known for its flagship Samuel Adams beer brand, the Boston Beer Company Inc (NYSE: SAM) is the owner of a portfolio of brands that includes Twisted Tea and Truly Hard Seltzer.
If You Invested $1,000 When Jim Cramer Said Buy These 5 Stocks, Here’s How Much You’d Have Now
Love him or hate him, Jim Cramer has a massive audience.
Amazon’s On-Again, Off-Again Big Bets On Health Care Sector
In its most recent entry into the health care industry, Amazon.com, Inc.
‘Supreme Court says Biden cannot reinstate policy limiting ICE arrests, for now’ -Washington Post Report
https://www.washingtonpost.com/national-security/2022/07/21/supreme-court-biden-ice-immigration-enforcement/
Why Meta Platforms Stock Is Falling After Hours
Meta Platforms Inc (NASDAQ: META) shares are trading lower in Thursday's after-hours session in sympathy with Snap Inc (NASDAQ: SNAP), which reported worse-than-expected financial results.
After-Hours Alert: Why Pinterest Stock Is Falling
Pinterest Inc (NYSE: PINS) shares are trading lower in Thursday's after-hours session in sympathy with social media peer Snap Inc (NYSE: SNAP), which reported worse-than-expected financial results.
Snap Q2 Earnings Highlights: Stock Tanks On No Q3 Guidance, Revenue And EPS Miss
Camera company and Snapchat parent company Snap Inc (NYSE: SNAP) is falling after-hours Thursday after reporting second-quarter financial results. Here are the key highlights.
ClearPoint Neuro Congratulates Partner PTC Therapeutics On Being Granted Marketing Authorization By The European Commission For Upstaza – First Disease-Modifying Treatment For AADC Deficiency
ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global therapy-enabling platform company providing navigation and delivery to the brain, congratulates partner PTC Therapeutics for being granted